Safety of gastrodin injection in healthy adults
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new injection called Gastrodin, which comes from a plant used in traditional medicine. The goal is to see if it's safe and how the body processes it in healthy people. It might help with conditions related to the brain or blood flow in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult between 18 and 65 years old.
- Weigh at least 50 kg (about 110 pounds) if you are male, or 45 kg (about 99 pounds) if you are female.
- Have a body mass index (BMI) between 19 and 26.
- Be willing to use effective birth control during the study and for 3 months after the last dose.
- Have no serious medical conditions, no recent surgeries, and no allergies to the study drug.
- Avoid taking certain medications, alcohol, tobacco, and caffeine in the weeks before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.
This trial is testing an investigational medication called GR2301 in healthy adults. It aims to see how the drug behaves in the body and if it is safe, which is a first step before studying it in people with medical conditions.
This trial tests a new sedative medication called Methoxyethyl Etomidate Hydrochloride, given to keep you relaxed and pain-free during a gastroscopy or colonoscopy. The medication aims to be safe and effective for routine procedures.
This trial tests an investigational drug called GR2301 in healthy volunteers to see if it is safe. It is a phase 1 study, which means it is the first time this drug is being given to people.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.
Hear when a new Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.